Christopher L Bowlus

30PUBLICATIONS

112CO-AUTHORS

Toxicology (incl. clinical toxicology)Pacific Peoples biomedical and clinical sciencePharmacogenomicsPredictive and prognostic markersGlycoconjugates

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (30)

Sort by Publication Date:

|Jul 14, 2026

Long-Term Safety and Efficacy of Obeticholic Acid in Patients With Primary Biliary Cholangitis: Final Results of the POISE Long-Term Safety Extension.

|May 18, 2026

Evolving Concepts of Treatment Targets for Primary Biliary Cholangitis: A Global Perspective.

|Apr 13, 2026

Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies.

Stuart C Gordon, Alejandra Villamil, Ira M Jacobson

|Mar 02, 2026

Impact of Alkaline Phosphatase Normalization on Complication-Free Survival in Primary Biliary Cholangitis.

Anish Reddy, Adrielly Martins, Christopher L Bowlus

|Nov 19, 2025

Nebokitug, an Anti-chemokine (C-C Motif) Ligand 24 Monoclonal Antibody, in Patients With Primary Sclerosing Cholangitis: A Phase 2 Study.

Christopher L Bowlus, Douglas Thorburn, Stephen T Barclay

|Oct 16, 2025

Spatial heterogeneity in liver stiffness does not predict clinical outcomes in patients with primary sclerosing cholangitis.

Erick Cruz Grave, Connie Chan, Michael T Corwin

Pageof 5

Frequent Collaborators

12 joint publications

Cynthia Levy

Marlyn J Mayo

Stuart C Gordon

Lisa M Forman

Gideon M Hirschfield

Palak Trivedi

Charles A McWherter

John M Vierling

Andreas E Kremer

Mercedes Martinez

Frequent Collaborators

12 joint publications

Cynthia Levy

6 joint publications

Marlyn J Mayo

4 joint publications

Stuart C Gordon

4 joint publications

Lisa M Forman